136 related articles for article (PubMed ID: 7557247)
21. Gastric mucosal EGF and PDGF receptor expression with ulcer healing by ebrotidine.
Slomiany BL; Piotrowski J; Czajkowski A; Yotsumoto F; Slomiany A
Am J Gastroenterol; 1994 Jun; 89(6):894-7. PubMed ID: 8198101
[TBL] [Abstract][Full Text] [Related]
22. Ebrotidine--a nostrum for ulcer.
Grover JK; Rathi SS; Vats V
Trop Gastroenterol; 1997; 18(3):111-3. PubMed ID: 9385853
[No Abstract] [Full Text] [Related]
23. Enhancement of the protective qualities of gastric mucus by sucralfate: role of phosphoinositides.
Slomiany BL; Piotrowski J; Tamura S; Slomiany A
Am J Med; 1991 Aug; 91(2A):30S-36S. PubMed ID: 1715671
[TBL] [Abstract][Full Text] [Related]
24. Effects of sofalcone administration on the physicochemical properties of gastric mucus.
Slomiany BL; Tamura S; Piotrowski J; Slomiany A
J Clin Gastroenterol; 1992; 14 Suppl 1():S88-93. PubMed ID: 1378469
[TBL] [Abstract][Full Text] [Related]
25. Reversal of gastric somatostatin receptor inhibition by Helicobacter pylori lipopolysaccharide with ebrotidine and sulglycotide.
Piotrowski J; Skrodzka D; Slomiany A; Slomiany BL
Gen Pharmacol; 1997 May; 28(5):705-8. PubMed ID: 9184806
[TBL] [Abstract][Full Text] [Related]
26. Nature of the enhancement of the protective qualities of gastric mucus by sucralfate.
Slomiany BL; Piotrowski J; Okazaki K; Grzelinska E; Slomiany A
Digestion; 1989; 44(4):222-31. PubMed ID: 2483693
[TBL] [Abstract][Full Text] [Related]
27. Gastroprotective and ulcer-healing activities of a new H2-receptor antagonist: ebrotidine.
Brzozowski T; Majka J; Konturek SJ
Digestion; 1992; 51(1):27-36. PubMed ID: 1353465
[TBL] [Abstract][Full Text] [Related]
28. Role of mucus in gastric mucosal protection.
Slomiany BL; Slomiany A
J Physiol Pharmacol; 1991 Jun; 42(2):147-61. PubMed ID: 1782415
[TBL] [Abstract][Full Text] [Related]
29. Gastric mucosal hydrophobicity in duodenal ulceration: role of Helicobacter pylori infection density and mucus lipids.
Asante M; Ahmed H; Patel P; Davis T; Finlayson C; Mendall M; Northfield T
Gastroenterology; 1997 Aug; 113(2):449-54. PubMed ID: 9247463
[TBL] [Abstract][Full Text] [Related]
30. Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine.
Arroyo MT; Lanas A; Sáinz R
Eur J Gastroenterol Hepatol; 2000 Mar; 12(3):313-8. PubMed ID: 10750652
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of Helicobacter pylori urease activity by ebrotidine.
Piotrowski J; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1995 Oct; 37(2):247-53. PubMed ID: 8673007
[TBL] [Abstract][Full Text] [Related]
33. Effect of antiulcer agents on the physicochemical properties of gastric mucus.
Slomiany BL; Murty VL; Piotrowski J; Slomiany A
Symp Soc Exp Biol; 1989; 43():179-91. PubMed ID: 2518222
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Helicobacter pylori colonization by an antiulcer agent, sulglycotide.
Czajkowski A; Piotrowski J; Yotsumoto F; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1993 Apr; 29(5):965-71. PubMed ID: 8508147
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine.
Piotrowski J; Piotrowski E; Slomiany A; Slomiany BL
J Physiol Pharmacol; 1995 Dec; 46(4):463-9. PubMed ID: 8770790
[TBL] [Abstract][Full Text] [Related]
36. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of Helicobacter pylori pathogenesis: focus on mucus.
Slomiany BL; Slomiany A
J Clin Gastroenterol; 1992; 14 Suppl 1():S114-21. PubMed ID: 1378466
[TBL] [Abstract][Full Text] [Related]
38. Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine.
Slomiany BL; Piotrowski J; Slomiany A
Scand J Gastroenterol; 1997 Jul; 32(7):638-42. PubMed ID: 9246701
[TBL] [Abstract][Full Text] [Related]
39. Gastroprotective agents in mucosal defense against Helicobacter pylori.
Slomiany BL; Murty VL; Piotrowski J; Slomiany A
Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626
[TBL] [Abstract][Full Text] [Related]
40. Effects of melatonin and tryptophan on healing of gastric and duodenal ulcers with Helicobacter pylori infection in humans.
Celinski K; Konturek PC; Konturek SJ; Slomka M; Cichoz-Lach H; Brzozowski T; Bielanski W
J Physiol Pharmacol; 2011 Oct; 62(5):521-6. PubMed ID: 22204799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]